Personal and financial costs of ADHD in Australia revealed

October 26, 2020

Researchers have revealed the key factors that can improve outcomes in children with ADHD, a disorder that costs Australia US$13 billion a year in social and economic losses.

Research, led by the Murdoch Children's Research Institute (MCRI) and published in Pediatrics, highlighted the importance of identifying academic, behavioural and social functioning difficulties in the first years of school and empowering teachers and parents to intervene early.

The Journal of Attention Disorders study, led by the Australian ADHD Professionals Association (AAPDA) and Deloitte Access Economics in collaboration with MCRI researchers, revealed for the first time the true social and economic cost of ADHD to the Australian community.

The financial and non-financial costs of ADHD in Australia reached US$12.75 billion or US$14,575 per person during the 2018/2019 financial year.

MCRI Associate Professor Daryl Efron said little quality evidence had existed on the factors that influence changes in ADHD symptoms and impairments over time.

The Pediatrics study followed 477 children at age seven from the Children's Attention Project over three years, and tracked their performance across a range of areas compared to children without ADHD. Only a minority of participants had been treated with medication.

The study found that children with ADHD who had a poor working memory (a limited capacity to hold information temporarily) at age seven tended to have poorer academic performance at age 10 year whereas ADHD symptom severity was linked to their emotional-behavioral outcomes. Children with ADHD who also had autism spectrum disorder symptoms at seven had poorer emotional and social functioning at 10 years of age.

Associate Professor Efron said given children with ADHD go on to experience persisting problems, early identification and treatment may help improve outcomes.

"The predictors for those who had worse outcomes were significant irrespective of whether children meet diagnostic ADHD criteria, suggesting clinicians should monitor children with symptoms even when they fall below the diagnostic threshold," he said.

"Our results suggest that a broad clinical approach is needed to manage ADHD which includes not only symptom management, but also identification and management of other conditions which often coexist with ADHD."

Associate Professor Efron said the research showed children with ADHD who had academic delays could be identified by teachers without the need for formal assessment, which could speed up intervention.

Prior to the Journal of Attention Disorders paper no international studies have comprehensively mapped the social and economic costs of ADHD across multiple areas and included both children and adults.

AADPA president Professor Mark Bellgrove said the data would help to shine a light on ADHD as a serious mental health condition in Australia and would hopefully improve public policy.

The study found the total financial costs associated with ADHD in Australia were about US$7.45 billion. The financial total includes productivity losses (mostly due to absenteeism, presenteeism and reduced employment) of US$6 billion, health system costs of US$321.1 million, educational costs of US$74.1 million, crime and the justice system costs US$215 million and deadweight losses arising from the need to levy taxes to fund government expenditure on services and programs and reduced taxation revenue was US$790.9 million.

The non-financial costs of lost wellbeing associated with reduced quality of life and premature deaths linked to ADHD amounted to US$5.31 billion.

MCRI and Deakin University Associate Professor Emma Sciberras said the considerable socioeconomic impact and burden of ADHD should drive investment and policy decisions to improve ADHD identification and treatment.

"This data points to the considerable public health significance of ADHD and the need for expansion of clinical services for the condition, as well as increased research investment," she said.

In Australia 3.2 per cent (814,500) of people and one in 20 children have ADHD.

MCRI and University of Melbourne Professor David Coghill said the many structural challenges facing ADHD services should be rapidly addressed.

"One particular barrier to care facing young people with ADHD is the high risk of discontinuity of treatment when transitioning from paediatric to youth and/or adult services," he said.

"The complex reasons for this include poor transition planning, lack of available services and trained professionals in the area, other life transitions occurring at the same time, and the shift during adolescence towards increased independence.

"There is also a need to improve screening approaches that can identify those at risk of ADHD early in life, which will go a long way to reducing the associated costs and burdens."

Professor Coghill said with 81 per cent of the financial costs due to lost productivity, more workplace support was needed to help those with ADHD.

"Medication is likely to result in multiple functional benefits and additionally adjustments in the workplace can be considered, however, further research is needed to demonstrate the real world effectiveness and cost-effectiveness of such approaches," he said.

Researchers from the University of Melbourne, The Royal Children's Hospital, Monash University, La Trobe University, National Institute for Health Research Applied Research Collaboration in the UK, The University of Sydney, Joondalup Child Development Centre, University of Western Australia, Deloitte Access Economics, Metro North Mental Health Service, Brisbane, QIMRB Research Institute Herston, Queensland Centre for Mental Health Research, University of Queensland, Children's Health Queensland Hospital and Health Service, Vrije Universiteit Amsterdam, Children's Hospital at Westmead and the Hollywood Specialist Centre, Western Australia, also contributed to one or both studies.
-end-
Publication: Daryl Efron, Jan M. Nicholson, Vicki Anderson, Tim Silk, Obioha C Ukoumunne, Alisha Gulenc, Philip Hazell, Brad Jongeling and Emma Sciberras. 'ADHD at Age 7 and Functional Impairments at Age 10,' Pediatrics. DOI: 10.1542/peds.2020-1061

Publication: Emma Sciberras, Jared Streatfeild, Tristan Ceccato, Lynne Pezzullo, James G. Scott, Christel M. Middeldorp, Paul Hutchins, Roger Paterson, Mark A Bellgrove and David Coghil. 'Social and Economic Costs of Attention-Deficit/Hyperactivity Disorder Across the Lifespan,' Journal of Attention Disorders. DOI: 10.1177/1087054720961828

*The content of this communication is the sole responsibility of MCRI and does not reflect the views of the NHMRC.

Available for interview:

Associate Professor Daryl Efron
Associate Professor Emma Sciberras
Professor David Coghill

Murdoch Childrens Research Institute

Related ADHD Articles from Brightsurf:

Autism and ADHD share genes
Researchers from the national psychiatric project iPSYCH have found that autism and ADHD share changes in the same genes.

ADHD across racial/ethnic groups
This study of patients from diverse racial/ethnic backgrounds who received care at the Kaiser Permanente Northern California health system looked at how common attention-deficit/hyperactivity disorder (ADHD) diagnoses were over a 10-year period across seven racial/ethnic groups.

Cycles of reward: New insight into ADHD treatment
Researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats.

Young mums more likely to have kids with ADHD
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder (ADHD) according to new research from the University of South Australia.

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Antipsychotic use in youths with ADHD is low, but still cause for concern
A new study eased fears about the proportion of youths with ADHD taking antipsychotic drugs, but still found that many prescriptions may be inappropriate.

How stimulant treatment prevents serious outcomes of ADHD
Analysis quantifies the extent which stimulant treatment reduces serious outcomes in children and young adults with ADHD.

Did Leonardo da Vinci have ADHD?
Leonardo da Vinci produced some of the world's most iconic art, but historical accounts show that he struggled to complete his works.

More sleep may help teens with ADHD focus and organize
Teenagers with attention deficit hyperactivity disorder (ADHD) may benefit from more sleep to help them focus, plan and control their emotions.

Researchers have found the first risk genes for ADHD
A major international collaboration headed by researchers from the Danish iPSYCH project, the Broad Institute of Harvard and MIT, Massachusetts General Hospital, SUNY Upstate Medical University, and the Psychiatric Genomics Consortium has for the first time identified genetic variants which increase the risk of ADHD.

Read More: ADHD News and ADHD Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.